Evidence map›Paper›PMID 42847501›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2026

Co-Designing Medication Safety Interventions for Community Pharmacy: Bringing Together People Living With Visual Impairments and Community Pharmacists Using a Modified Nominal Group Technique Approach.

Isabel Adeyemi, Lisa Riste, Penny Lewis, Adam Pearson, Sumaira Naseem, Rebecca Morris, Darren Ashcroft, Maria Panagioti, Caroline Sanders, Sally Giles

Abstract read
PubMed Publisher
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Isabel AdeyemiNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0003-4912-9385
Lisa RisteNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0003-2606-0717
Penny LewisDivision of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), Manchester, Lancashire, UK.
Adam PearsonNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.
Sumaira NaseemNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.
Rebecca MorrisCentre for Primary Care, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0003-1587-0802
Darren AshcroftNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0002-2958-915X
Maria PanagiotiNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0002-7153-5745
Caroline SandersNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0002-0539-928X
Sally GilesNIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, Lancashire, UK.ORCID https://orcid.org/0000-0003-1623-6029

Funding

National Institute for Health and Care ResearchNational Institute for Health and Care Research Greater Manchester Patient Safety Research Collaboration
6 · The paper itself

Abstract

introductionPeople living with visual impairment (VI), defined as a reduction in visual acuity or visual field that cannot be corrected by spectacles or contact lenses, experience health inequalities and are at increased risk of medication-related safety incidents. This study aimed to identify challenges contributing to medication errors and to co-design potential solutions with people living with VI and community pharmacy professionals.

methodsA modified Nominal Group Technique (mNGT) was conducted with seven adults living with VI and six community pharmacy professionals. The process comprised four stages: problem identification, solution generation, decision making and prioritisation, implementation and intervention development.

resultsParticipants identified twelve medication safety challenges and generated twenty-four potential solutions spanning pharmacist training, patient and pharmacist resources, pharmacy consultations, system changes and assistive technologies. Following discussion and prioritisation, three interventions were selected for further development: (1) an accessible Patient Safety Guide (PSG) to support communication between pharmacists, patients and carers regarding safe medication use; (2) a training video for pharmacists to improve awareness and understanding of the needs of people living with VI; and (3) pharmacy system changes, such as alerts or pop-up notifications, to improve identification of people living with VI and facilitate personalised support.

conclusionCo-design involving people living with VI and community pharmacy professionals successfully identified practical and acceptable interventions with potential to improve medication safety. The findings highlight the importance of communication, pharmacist awareness and system-level support in reducing medication-related risks for people living with VI. PATIENT OR PUBLIC CONTRIBUTION: People living with visual impairment (PwVI) were involved throughout the design, conduct, and interpretation of this study. A stakeholder consultation group comprising PwVI and a carer informed the development of the study protocol, accessibility adaptations, workshop structure, and supporting materials. PwVI participated directly in the co-design workshops, identifying problems, generating solutions, and contributing to prioritisation of intervention ideas. Several PwVI also provided feedback on interpretation of findings and contributed to refining accessible outputs, including adaptations to the patient safety guide. Their involvement ensured that the research remained grounded in lived experience, and that the interventions developed reflected the priorities and practical realities of those directly affected.

Indexed as

Community Pharmacy ServicesMedication ErrorsPatient SafetyPersons with Visual DisabilitiesPharmacistsVision DisordersAdultAgedFemaleHumansMaleMiddle Agedco‐productionpatient safetypharmacy

Identifiers

PMID42847501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.